Presenting Longitudinal Data

References 

1. Witzig TE , Silberstein PT , Loprinzi CL , Sloan JA , Novotny PJ , Mailliard JA , et al.   Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy . J Clin Oncol . 2005;23(12):2606–2617
   • MEDLINE
   • CrossRef
2. Sloan JA . Statistical issues in the application of cancer outcome measures . In:  Lipscomb J ,  Gotay C ,  Snyder C editor. Outcomes Assessment . New York, NY: Cambridge University Press; 2005;p. 362
3. Sloan JA , Schaefer PL , Witzig TE , Novotny PJ , Silberstein PT , Beardon J , et al.   Relationships among quality of life and survival in anemic patients with advanced cancer undergoing chemotherapy, Abstract 6027, ASCO . 2005;
4. Albert PS . Longitudinal data analysis (repeated measures) in clinical trials . Stat Med . 1999;18:1707–1732
   • MEDLINE
   • CrossRef
5. Diggle PJ , Liang KY , Zeger SL . Analysis of Longitudinal Data . New York, NY: Oxford University Press; 1993;
6. Fairclough DL . Summary measures and statistics for comparison of quality of life in a clinical trial of cancer therapy . Stat Med . 1997;16:1197–1209
   • MEDLINE
7. Sloan JA , Dueck A . Issues for statisticians in conducting analyses and translating results for quality of life endpoints in clinical trials . J Biopharm Stat . 2004;14(1):73–96
   • MEDLINE
   • CrossRef
8. Smith D , Atherton PJ , Tan A , Novotny PJ , Sloan JA . Analyzing and Displaying Study Data in Clinical Trials Made Easy, Paper SP08, PharmaSUG Proceedings . 2005;